1. Home
  2. MAMA vs TECX Comparison

MAMA vs TECX Comparison

Compare MAMA & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$13.76

Market Cap

474.8M

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$18.75

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAMA
TECX
Founded
2010
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
474.8M
359.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MAMA
TECX
Price
$13.76
$18.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$17.00
$81.20
AVG Volume (30 Days)
499.5K
301.7K
Earning Date
12-08-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
41.91
N/A
EPS
0.12
N/A
Revenue
$151,312,000.00
N/A
Revenue This Year
$35.43
N/A
Revenue Next Year
$28.82
N/A
P/E Ratio
$111.49
N/A
Revenue Growth
29.92
N/A
52 Week Low
$5.50
$13.70
52 Week High
$14.50
$61.07

Technical Indicators

Market Signals
Indicator
MAMA
TECX
Relative Strength Index (RSI) 68.85 47.66
Support Level $11.04 $18.60
Resistance Level $14.50 $19.99
Average True Range (ATR) 0.75 1.38
MACD 0.21 -0.24
Stochastic Oscillator 74.25 24.70

Price Performance

Historical Comparison
MAMA
TECX

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: